FNY Investment Advisers’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Hold
1,000
0.01% 538
2026
Q1
$22K Hold
1,000
0.01% 456
2025
Q4
$11K Sell
1,000
-1,000
-50% -$12.8K ﹤0.01% 644
2025
Q3
$31K Sell
2,000
-2,000
-50% -$29K 0.01% 604
2025
Q2
$45K Buy
4,000
+2,000
+100% +$22.5K 0.02% 420
2025
Q1
$27K Buy
+2,000
New +$33.2K 0.02% 360
2021
Q1
Sell
-1,970
Closed -$48K 809
2020
Q4
$48K Buy
+1,970
New +$46.9K 0.01% 398
2020
Q1
Sell
-2,250
Closed -$40K 496
2019
Q4
$40K Buy
2,250
+1,950
+650% +$32.4K 0.01% 507
2019
Q3
$4K Buy
+300
New +$4.88K ﹤0.01% 664
2018
Q3
Sell
-30
Closed -$1K 942
2018
Q2
$1K Buy
+30
New +$1.49K ﹤0.01% 897

Other funds holding CC

FNY Investment Advisers's CC Position: Q2 2026 in Review

FNY Investment Advisers held its Chemours (CC) position steady in Q2 2026 at 1,000 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #538.

FNY Investment Advisers first reported a position in CC in Q2 2018 and has held it in 10 quarters since. The position peaked at $48K in Q4 2020. 157 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • FNY Investment Advisers held 1,000 shares of Chemours worth $20K as of Q2 2026.
  • FNY Investment Advisers left its Chemours share count unchanged in Q2 2026.
  • Chemours made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #538 holding.
  • FNY Investment Advisers first reported a position in Chemours in Q2 2018 and has held it in 10 quarters since.
  • FNY Investment Advisers's Chemours position peaked at $48K in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.